Surf Wiki
Save to docs
general/designer-drugs

From Surf Wiki (app.surf) — the open knowledge base

LGD-2226

Chemical compound

Chemical compound

| elimination_half-life =

LGD-2226 is an investigational selective androgen receptor modulator (SARM), which is being developed for treatment of muscle wasting and osteoporosis.

LGD-2226 is an orally active, potent and selective agonist for androgen receptors which was shown to have anabolic effects in both muscle and bone tissue, but with considerably less effects on prostate weight and luteinizing hormone levels than testosterone.

Selective androgen receptor modulators may also be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids but with significantly less side effects. For this reason, SARMs have already been banned by the World Anti-Doping Agency since January 2008 despite no drugs from this class yet being in clinical use, and blood tests for all known SARMs are currently being developed, including LGD-2226.

It was encountered as a novel designer drug by at least 2020.

References

References

  1. (October 2006). "Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator". Journal of Medicinal Chemistry.
  2. (March 2007). "Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)". Drug Discovery Today.
  3. (January 2007). "An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate". Endocrinology.
  4. (March 2008). "Cell-specific activation of the human skeletal alpha-actin by androgens". Endocrinology.
  5. (May 2008). "Mass spectrometry of hydantoin-derived selective androgen receptor modulators". Journal of Mass Spectrometry.
  6. (May 2008). "Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS". Analytical and Bioanalytical Chemistry.
  7. (2007). "Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis". Rapid Communications in Mass Spectrometry.
  8. "LGD-2226".
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

designer-drugs lactams organofluorides quinolines selective-androgen-receptor-modulators trifluoroethyl-compounds trifluoromethyl-compounds
Want to explore this topic further?

Ask Mako anything about LGD-2226 — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report